Kymera Therapeutics
KYMR
KYMR
136 hedge funds and large institutions have $1.55B invested in Kymera Therapeutics in 2023 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 36 increasing their positions, 53 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
136
Holders Change
+15
Holders Change %
+12.4%
% of All Funds
1.99%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
33
Increased
36
Reduced
53
Closed
18
Calls
$1.97M
Puts
$433K
Net Calls
+$1.53M
Net Calls Change
+$913K
Top Buyers
| 1 |
BBA
Baker Bros. Advisors
New York
|
$153M |
| 2 |
AG
Artal Group
Luxembourg
|
$64.4M |
| 3 |
Morgan Stanley
New York
|
$22.5M |
| 4 |
Goldman Sachs
New York
|
$17.2M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
$11.1M |
